Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Dequalinium chloride (Decabis) , a topical bacteriostat, is a selective blocker of apamin-sensitive K+ channels. It is used in wound dressings and mouth infections and may also have antifungal action, but may cause skin ulceration.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
25 mg | 在庫あり | ¥ 9,000 | |||
50 mg | 在庫あり | ¥ 13,000 | |||
100 mg | 在庫あり | ¥ 19,000 | |||
200 mg | 在庫あり | ¥ 28,000 |
説明 | Dequalinium chloride (Decabis) , a topical bacteriostat, is a selective blocker of apamin-sensitive K+ channels. It is used in wound dressings and mouth infections and may also have antifungal action, but may cause skin ulceration. |
ターゲット&IC50 | PKC:7 μM-18 μM |
In vitro | Dequalinium chloride effectively inhibits nicotinic responses in skeletal muscles and potassium ion channels sensitive to apamin in bee venom in hepatocytes. It also acts as a ganglionic blocking agent (EC50: 2 μM) and, as a cationic lipophilic PKC inhibitor, shares a similar structure with the dye Rhodamine 123. Dequalinium chloride irreversibly inhibits PKCα/β through covalent binding under UV irradiation. It selectively accumulates in the mitochondria of tumor cells, inducing mitochondrial toxicity by blocking mitochondrial enzymes, thereby disrupting cellular energy production and leading to cell death. Dequalinium inhibits the binding of 125I-monoiodoapamin (Ki: 1.1 μM) and prevents potassium ion loss (induced by angiotensin II, IC50: 1.5 μM). In cultured rat sympathetic neurons, Dequalinium reversibly inhibits the slow component of the afterhyperpolarization (AHP) sensitive to apamin, subsequently generating a single action potential. |
In vivo | In mice bearing MB49 bladder tumor xenografts, Dequalinium chloride (2 mg/kg/day i.p.) exhibited anticancer activity with a T/C value of 210%. |
別名 | Dequafungan, Danical, Decabis |
分子量 | 527.59 |
分子式 | C30H40Cl2N4 |
CAS No. | 522-51-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: Insoluble
H2O: 3.3mg/ml(6.3mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Dequalinium chloride 522-51-0 Chromatin/Epigenetic Cytoskeletal Signaling Membrane transporter/Ion channel PKC Potassium Channel Dequalinium Dequafungan Dequalinium Chloride Danical inhibit Inhibitor KcsA Decabis inhibitor